Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
---|
10/14/1992 | EP0508234A2 Beta-lactames |
10/14/1992 | EP0508221A1 Somatostatin receptor |
10/14/1992 | EP0507938A1 Bis-(hydroxyalkylamino)-anthraquinone inhibitors of protein kinase c |
10/14/1992 | CN1065267A Heterocyclic-cyclic amine derivatives |
10/14/1992 | CN1065202A Cosmetics |
10/14/1992 | CN1018640B Process for the preparation of compounds for the induction of in vivo and in vitro production of cytokines |
10/14/1992 | CN1018614B Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines |
10/13/1992 | US5155259 Aldose reductase inhibitor |
10/13/1992 | US5155249 Differentiating neoplastic cells, treating psoriasis, immune or inflammatory diseases |
10/13/1992 | US5155218 Dna encoding human 5-ht1d receptors |
10/13/1992 | US5155217 Ongogene encoding polypeptide having growth factor activity |
10/13/1992 | US5155125 Orally Administering; having an aldose reductase inhibitory activity |
10/13/1992 | US5155121 Phenylsulphonamide substituted pyridinealkene- and aminooxyalkanecarboxylic acid derivatives |
10/13/1992 | US5155115 Thienopyridine derivatives |
10/13/1992 | US5155104 Phenylalkan(en)oic acid |
10/13/1992 | US5155101 Cholecystokinin antagonist; preventing emesis or pancreatitis |
10/13/1992 | US5155100 Treating cardiovascular disorders in mammals |
10/13/1992 | US5155099 Alkylphosphonoserines and pharmaceutical compositions useful as cytostatic agents |
10/13/1992 | CA2065228A1 Tetronic and thiotetronic acid derivatives as phospholipase a2 inhibitors |
10/13/1992 | CA1308728C 5-alkoxy-1-benzoyl-2-oxopyrrolidine; process for preparing the same; their useas drugs and compositions containing them |
10/13/1992 | CA1308721C Benzimidazol-2-one derivatives and their salts; process and intermediates for preparing the same; their use as drugs; compositions containing them |
10/13/1992 | CA1308660C Pharmaceutical compositions containing 1,3-dioxane alkenoic acid derivatives |
10/12/1992 | CA2064945A1 .beta.-lactams |
10/11/1992 | WO1992018002A1 Nitrosation of homocysteine as a method for treating homocysteinemia |
10/11/1992 | CA2108152A1 Nitrosation of homocysteine as a method for treating homocysteinemia |
10/11/1992 | CA2065715A1 Cholecystokinin antagonists |
10/11/1992 | CA2065703A1 Cholecystokinin antagonists |
10/11/1992 | CA2065530A1 Saliva substitute |
10/09/1992 | WO1992017444A1 Thiol-carboxylic acid derivatives as collagenase inhibitors |
10/09/1992 | CA2107334A1 Thiol-carboxylic acid derivatives as collagenase inhibitors |
10/09/1992 | CA2065049A1 Angiotensin ii antagonists incorporating an indole or dihydroindole |
10/07/1992 | EP0507696A1 Antihistaminic and non-sedative derivatives of benzimidazol, process for their preparation and their medicinal use |
10/07/1992 | EP0507604A2 Ionically crosslinked carboxyl-containing polysaccharides for adhesion prevention |
10/07/1992 | EP0507594A1 Substituted quinolines as angiotensin II antagonists |
10/07/1992 | EP0507348A2 Superoxide dismutase derivatives |
10/07/1992 | EP0507224A2 Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
10/07/1992 | EP0507190A1 Compositions with physiological cooling effect and active compounds suitable for such compositions |
10/07/1992 | EP0507187A1 Method for inhibiting pulmonary oxygen toxicity |
10/07/1992 | EP0506905A1 Piperazine derivatives |
10/07/1992 | EP0506813A1 5-ht 3? antagonists for treatment of nausea, bradycardia of hypotension associated with myocardial instability |
10/07/1992 | CN1065063A 1-biphenylmethyl imidazole derivatives, their preparation and their therapeutic use |
10/07/1992 | CN1065009A Process for preparing composition for beauty or pharmaceutical, especially dermtoses and anti-allergy and use |
10/06/1992 | WO1992017440A1 Tricyclic compound |
10/06/1992 | USRE34091 Sialic acid derivatives having active carbonyl group |
10/06/1992 | US5153308 S-sulfonated calcitonin derivatives |
10/06/1992 | US5153227 Phenylsulfonyl nitromethanes as aldose reductase inhibitors |
10/06/1992 | US5153206 Neuroleptic agents for treating psychological disorders |
10/06/1992 | US5153205 Method to reduce introacular pressure without causing miosis |
10/06/1992 | US5153192 For controlling intraocular pressure |
10/06/1992 | US5153183 Methylenediphosphonic acid compounds and methods of use for the treatment of rheumatism and osteophorosis |
10/06/1992 | US5153181 Administering a polysaccharides containing sulfate groups |
10/06/1992 | CA2106979A1 Tricyclic compound |
10/06/1992 | CA2065061A1 Benzimidazole-derived non sedative antihistamines |
10/06/1992 | CA2064918A1 Compositions having a physiological cooling effect and active compounds suitable for these compositions |
10/06/1992 | CA2064654A1 Substituted quinolines as angiotensin ii antagonists |
10/05/1992 | WO1992017451A1 Pyridine- and imidazole-derived agents for cardiovascular diseases |
10/01/1992 | WO1992016666A1 N6-(hydrazinoiminomethyl)lysine and method of inhibiting nitric oxide formation in body |
10/01/1992 | WO1992016524A1 Benzo-fused lactams promote release of growth hormone |
10/01/1992 | WO1992016496A1 N-[[4,5-dihydroxy- and 4,5,8-trihydroxy-9,10-dihydro-9,10-dioxo-2-anthracene-yl]carbonyl]amino acids useful in the therapy of osteoarticular affections |
10/01/1992 | WO1992016213A1 Pharmaceutical combination for the treatment of prostatic hyperplasia, containing a 5 alpha-reductase inhibitor and an antiandrogen |
10/01/1992 | WO1992016203A1 Palytoxin-related prodrugs and a method for their administration |
10/01/1992 | WO1992016181A2 Composition for promoting tissue repair and regeneration |
09/30/1992 | WO1992017188A1 New non-anticoagulant heparin derivatives |
09/30/1992 | WO1992017187A1 New non-anticoagulant heparin derivatives |
09/30/1992 | WO1992017185A1 Targeted drug delivery via mixed phosphate derivatives |
09/30/1992 | EP0506565A1 Use of 4,9,11-trienic steroids in compositions for turkeys |
09/30/1992 | EP0506545A2 Use of 4-amino-1-(2-pyridyl)piperidines as 5-HT3-agonists for the treatment and prophylaxis of serotoninergic dysfunctions |
09/30/1992 | EP0506477A1 Vascular endothelial cell growth factor C subunit |
09/30/1992 | EP0506369A1 6-Heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[CD]indoles |
09/30/1992 | EP0506363A1 6-Heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd]indoles |
09/30/1992 | EP0506194A1 4-aryl-thiazole or imidazole derivatives |
09/30/1992 | EP0505893A1 Imidazopyridines |
09/30/1992 | EP0505841A2 Analgesic composition containing beta-carotene |
09/30/1992 | EP0505817A1 Use of phosphatidylserine and its derivatives for the manufacture of a medicament for the treatment of degenerative pathologies also associated with immune disfunctions |
09/30/1992 | EP0505778A1 Derivatives of substituted imidazol-2-one and process for their preparation |
09/30/1992 | EP0505640A1 Improved therapeutic method |
09/30/1992 | EP0505543A1 NOVEL p-SUBSTITUTED PHENYL 4-OXYBUTANE AMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
09/30/1992 | EP0505497A1 Wound treatment employing biologically active peptides |
09/30/1992 | EP0505487A1 Growth arrest of proliferating cells by transglutaminase inhibitors |
09/30/1992 | EP0505481A1 2-substituted 4,5-diphenyl-imidazoles |
09/30/1992 | CN1064813A Methods and compositions for treatment and repair of defects or lesions in cartilage |
09/30/1992 | CN1018452B Process for preparing azacycloalkane derivatives |
09/30/1992 | CA2108041A1 Targeted drug delivery via mixed phosphate derivatives |
09/30/1992 | CA2107365A1 New non-anticoagulant heparin derivatives |
09/30/1992 | CA2107362A1 New non-anticoagulant heparin derivatives |
09/29/1992 | US5151534 Antiallergens, antiinflammatory agents or skin disorders |
09/29/1992 | US5151513 N-heterocyclic alcohol derivatives |
09/29/1992 | US5151435 Angiotensin ii antagonists incorporating an indole or dihydroindole |
09/29/1992 | US5151433 Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulations |
09/29/1992 | US5151423 Antiinflammatory agents or antiallergens |
09/29/1992 | US5151412 Pharmaceutically active conjugates having improved body tissue binding specificity |
09/29/1992 | US5151360 Antitumor agents or anticarcinogenic agents |
09/29/1992 | US5151274 Calcium and trace mineral supplements |
09/29/1992 | CA2064384A1 6-heterocyclic-4-amino-1,3,4,5- tetrahydrobenz [cd] indoles |
09/29/1992 | CA2064363A1 6-heterocyclic-4-amino-1,2,2a,3,4,5- hexahydrobenz ¬cd| indoles |
09/29/1992 | CA2064358A1 Use of 4, 9, 11-trienic steroids in compositions for administration to turkeys |
09/29/1992 | CA2064114A1 Somatostatin receptor |
09/29/1992 | CA1308104C Hydrate form endo-4-amino-5-chloro-2-methoxy -n-[1-azabicyclo- (3,3,1)-non-4-yl]-benzamide hydrochloride |
09/29/1992 | CA1308028C Pharmaceutical compositions for treating adrenoleukodystrophy |
09/28/1992 | CA2063941A1 Use of 4-amino-1-(2-pyridyl)piperidines for the preparation of a medicament for the treatment and prophylaxis of conditions deriving from disorders of the serotoninergic systems mediated by 5-ht3 receptors |